Model
Edge
Avalo Therapeutics Inc.
0001810417
Filing Type
4
Filing Date
10/6/2022
Updated
10/7/22, 10:01 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership